threonine has been researched along with Budd-Chiari Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Darwish Murad, S; de Bruijne, EL; de Maat, MP; Haagsma, EB; Janssen, HL; Leebeek, FW; Rosendaal, FR; Tanck, MW; van Hoek, B | 1 |
1 other study(ies) available for threonine and Budd-Chiari Syndrome
Article | Year |
---|---|
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Budd-Chiari Syndrome; Carboxypeptidase B2; Case-Control Studies; Female; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Portal Vein; Risk Factors; Threonine; Venous Thrombosis | 2007 |